Marked Campylobacteriosis Decline after Interventions Aimed at Poultry, New Zealand by Sears, Ann et al.
Page 1 of 18 
DOI: 10.3201/eid1706.101272 
Suggested citation for this article: Sears A, Baker MG, Wilson N, Marshall J, Muellner P, 
Campbell DM, et al. Marked campylobacteriosis decline after interventions aimed at poultry, 
New Zealand. Emerg Infect Dis. 2011 Jun; [Epub ahead of print] 
Marked Campylobacteriosis Decline  
after Interventions Aimed at Poultry,  
New Zealand 
Ann Sears, Michael G. Baker, Nick Wilson, Jonathan Marshall, Petra Muellner,  
Donald M. Campbell, Robin J. Lake, and Nigel P. French 
Author affiliations: University of Otago, Wellington, New Zealand (A. Sears, M.G. Baker, N. Wilson); Massey 
University, Palmerston North, New Zealand (J. Marshall, P. Muellner, N.P. French); New Zealand Food Safety 
Authority, Wellington (D.M. Campbell); and Institute of Environmental Science and Research Ltd, Christchurch, New 
Zealand (R.J. Lake)  
Beginning in the early 1980s, New Zealand experienced rising annual rates of campylobacteriosis that 
peaked in 2006. We analyzed notification, hospitalization, and other data to explore the 2007–2008 drop 
in campylobacteriosis incidence. Source attribution techniques based on genotyping of Campylobacter 
jejuni isolates from patients and environmental sources were also used to examine the decline. In 2008, 
the annual campylobacteriosis notification rate was 161.5/100,000 population, representing a 54% 
decline compared with the average annual rate of 353.8/100,000 for 2002–2006. A similar decline was 
seen for hospitalizations. Source attribution findings demonstrated a 74% (95% credible interval 49%–
94%) reduction in the number of cases attributed to poultry. These reductions coincided with the 
introduction of a range of voluntary and regulatory interventions to reduce Campylobacter spp. 
contamination of poultry. The apparent success of these interventions may inform approaches other 
countries could consider to help control foodborne campylobacteriosis. 
Campylobacteriosis is a common bacterial gastroenteritis reported in New Zealand and 
many other industrialized countries, with most cases caused by Campylobacter jejuni (1,2). 
Campylobacteriosis has been a notifiable disease in New Zealand since 1980, and medical 
practitioners are required to report confirmed or suspected cases to their local public health Page 2 of 18 
service (3). Campylobacteriosis notifications rose steadily after campylobacteriosis first became 
notifiable and peaked in 2006 at >380 per 100,000 population (4). A concomitant increase in 
campylobacteriosis hospitalizations has been noted, which suggests this rise in notifications is 
unlikely to be artifactual (5). 
To help inform prevention and control strategies, research efforts have been directed at 
establishing the likely contributors to this rise in campylobacteriosis incidence. Consistent with 
international findings (6–8), New Zealand investigations implicated poultry meat as a significant 
source of foodborne sporadic campylobacteriosis (9–13). A relatively small case–control study in 
Christchurch in 1992–1993 reported several poultry-associated risk factors, including 
consumption of undercooked poultry (10). A larger national case–control study in 1994–1995 
reported similar findings, with a combined population-attributable risk of poultry-related 
exposures >50% (9). A systematic review also concluded that poultry consumption was a 
prominent risk factor for sporadic campylobacteriosis in New Zealand (11). Reports noted the 
rise in campylobacteriosis was closely correlated with an increase in consumption of fresh 
poultry (14). 
Microbiological source attribution approaches have also been used to estimate the 
contribution of different sources and transmission pathways of campylobacteriosis in New 
Zealand. These techniques involve examining the epidemiology of campylobacteriosis at the 
genotype level by comparing C. jejuni genotypes from humans with those found in a range of 
food and environmental sources. In 2005, a major source attribution study for campylobacteriosis 
was initiated at a sentinel surveillance site in the Manawatu region of New Zealand (12). 
Campylobacter spp. isolates from cases notified in the region were genotyped by using 
multilocus sequence typing (MLST) and compared with isolates recovered from food and 
environmental sources (12,13). Statistical modeling was used to apportion human cases to 
potential disease sources, thereby estimating each source’s relative importance (13,15,16). This 
modeling revealed that >50% of sporadic campylobacteriosis cases in the region were 
attributable to poultry (12,13). 
On the basis of these findings, public health professionals advocated for more rigorous 
controls on foodborne pathways of campylobacteriosis, particularly for poultry (3,14). One 
intervention promoted was the freezing of all fresh poultry meat to reduce levels of Page 3 of 18 
Campylobacter spp. contamination, with fresh poultry allowed to be sold only when it could be 
shown to pose a low risk to human health (3). In late 2006, the New Zealand Food Safety 
Authority (NZFSA) released a risk management strategy for reducing incidence of poultry-
associated foodborne campylobacteriosis. 
New Zealand has a highly integrated, closed system of poultry production, with all 
poultry meat available for retail sale being of domestic origin. Processors of chicken meat 
control most aspects of production, processing, and distribution; 3 processing companies supply 
>90% of chicken meat consumed in New Zealand, representing 95% of all poultry meat 
consumed (2). As a result, interventions applied to the local poultry industry affect all 
domestically consumed poultry. 
A marked decline in campylobacteriosis notifications was observed during 2007 and 
2008 (17). We investigated this decline to assess whether it was causally related to the poultry-
focused food safety interventions. 
Methods 
Descriptive Epidemiology 
Historic notification and hospitalization data were used to calculate annual rates of 
campylobacteriosis in New Zealand during 1980–2009 for notifications and 1996–2009 for 
hospitalizations. A detailed descriptive analysis was then undertaken to examine the 
epidemiology of campylobacteriosis for the 12-year period 1997–2008 on the basis of notified 
and hospitalized cases. 
Campylobacteriosis notification data are collated nationally by the Institute of 
Environmental Science and Research Ltd from notifications made by medical practitioners to 
their local public health service. During the study period, >96% of these notifications were 
culture-confirmed cases with the remainder being epidemiologically linked or other probable 
cases. Hospitalization data are collated by the Ministry of Health from information supplied by 
public hospitals. Analysis of hospitalized cases was based on patients with a principal diagnosis 
code for Campylobacter enteritis (International Classification of Diseases, 9th Revision, Clinical 
Modification, code 008.43, or International Classification of Diseases, 10th Revision, code 
A04.5). These data were further selected to exclude hospital transfers, readmissions within 30 Page 4 of 18 
days, and day cases (i.e., patients assessed in hospital for a short time but not requiring an 
overnight stay). Admissions to private hospitals were excluded because few patients with 
infectious diseases are admitted to such institutions and documentation is inconsistent. 
In a detailed descriptive analysis, temporal trends in disease incidence and distribution 
were examined according to patient age, sex, socioeconomic status, ethnicity, urban versus rural 
dwelling, region (health board area), and season. Case-patients were assigned rurality and 
deprivation scores on the basis of their home domicile. For rurality assignment, we used a 
Statistics New Zealand classification system, which defines 7 grades of rurality on the basis of 
population size and employment address (18). Socioeconomic status was measured by 
deprivation scores assigned according to the New Zealand Deprivation Index, an area-based 
measure of socioeconomic position derived from the 5-year Census of Population and Dwellings 
(19). 
The main descriptive analysis rates were calculated by using interpolated and 
extrapolated Census Usually Resident population data from 1996, 2001, and 2006. Rates for 
2008 and 2007 (with 2007 being the transition year, on the basis of the gradual implementation 
of interventions) were compared with the average annual rates for 2 baseline periods (1997–2001 
and 2002–2006). For the longer time-trend analysis, rates were calculated by using mid-year 
population estimates derived by Statistics New Zealand (20). 
To examine the stability of the notification system for enteric diseases during the period 
of interest, we compared rates for campylobacteriosis notification and hospitalization with rates 
for 3 other notifiable enteric diseases (salmonellosis, yersiniosis, and cryptosporidiosis). Ethical 
approval for this study was obtained from the Multi-Region Ethics Committee, Wellington, New 
Zealand. 
Source Attribution 
During March 2005–December 2008, C. jejuni isolates from human case-patients and 
environmental and food sources were collected in the Manawatu area and genotyped (sequence-
typed) by using MLST (12,16). Food samples were collected from fresh meat (poultry, beef, 
lamb) in retail stores, and environmental water samples were collected from swimming locations 
in rivers. Sheep and cattle feces were sampled from farms adjacent to the catchments of these 
rivers. Page 5 of 18 
Two models were used to apportion human cases to sources on the basis of sequence 
types: the modified Hald model and the Island model (12,15). The modified Hald model 
combines the prevalence of each C. jejuni sequence type among the sources with the observed 
number of human isolates of that type by using a Bayesian framework (15). This model includes 
source-specific and type-specific factors, and accounts for variation in the estimated prevalence. 
The source-specific factor gives a measure of the ability of a source to act as a vehicle for human 
infection, whereas the type-specific factor yields a measure of the ability of a particular sequence 
type to cause disease. 
The Island model uses an evolutionary model to assign sequence types to a particular 
source “island” or population (12). Mutation, recombination, and migration rates for isolates 
within and between each island are estimated by using the source isolates, and the posterior 
distribution of these estimates are then used to infer the origin of human isolates (12,13). To 
account for variations in food-processing practices that may affect the likelihood of human 
infection from each food source, we further extended both models to examine whether changes 
had occurred over time in the relative contribution of different sources to human 
campylobacteriosis (dynamic modeling) (21). 
Key Informant Interviews and Policy Review 
Key informants (n = 12), including industry and food safety experts, were interviewed to 
obtain information on interventions implemented to reduce Campylobacter spp. contamination in 
poultry. We used information from these interviews together with a review of policy documents 
from NZFSA and the poultry industry to formulate a summary of the interventions implemented 
from 2006 through 2008. 
Results 
Descriptive Epidemiology 
The time-trend analysis of annual notification and hospitalization rates demonstrates a 
steady rise and then a marked decline in the incidence of campylobacteriosis (Figure 1). In the 
detailed descriptive analysis covering 1997–2008, the 2008 annual rate for campylobacteriosis 
notifications was 161.5/100,000 population, representing a 54% decline compared with the 
average annual rate of 353.8 for 2002–2006 (Technical Appendix, Page 6 of 18 
www.cdc.gov/EID/content/17/6/pdfs/10-1272-Techapp.pdf). The 2008 campylobacteriosis 
hospitalization rate of 7.6/100,000 population represented a 56% decline compared with the 
average annual rate for 2002–2006 of 17.3/100,000 population (Technical Appendix). 
Statistically significant declines in notifications were evident across all analyzed 
population subgroups, although the magnitude of the declines varied (Figure 1). Similarly, 
significant decreases were seen for most subgroups for campylobacteriosis hospitalizations 
(Sears et al., unpub. data). 
For the 2002–2006 period (before the decline), a trend for lower notification rates was 
shown among those residing in more rural areas compared with those living in main urban areas 
(rate ratios [RR] <1 where the reference is “main urban areas”) (Figure 2). In contrast, 
significantly higher notification rates were observed among those residing in more rural areas 
compared to those living in main urban areas in 2008 (Figure 2; Technical Appendix), indicating 
greater declines in incidence occurred in urban areas than in rural areas during 2007–2008. 
The largest declines in campylobacteriosis notification rates between the average annual 
rate for 2002–2006 and the 2008 rate were seen in winter months (RR 0.38, 95% confidence 
interval [CI] 0.36–0.40), in urban populations (RR 0.42, 95% CI 0.41–0.43), in the age groups 
20–29 years and 30–39 years (RR 0.40, 95% CIs 0.38–0.43 and 0.37–0.43, respectively) and in 
the Asian ethnic group (RR 0.26, 95% CI 0.22–0.31) (Technical Appendix). 
Conversely, the smallest declines in notification rates comparing the 2008 rate with the 
average annual rate for 2002–2006 were seen in rural populations (RR 0.66, 95% CI 0.62–0.70), 
in the 0–4 and the >80 years-of-age groups (RR 0.63, 95% CI 0.59–0.67, and RR 0.61, 95% CI 
0.53–0.70 respectively) and in Maori, the indigenous people of New Zealand (RR 0.49, 95% CI 
0.44–0.55) (Technical Appendix). 
Figure 3 shows the temporal relationship between campylobacteriosis notification rates 
for 1997–2008 and 3 other notifiable enteric diseases. The marked decline in campylobacteriosis 
notifications during 2007–2008 is evident, while over this same period, salmonellosis, 
cryptosporidiosis, and yersiniosis rates remained relatively stable  Page 7 of 18 
Source Attribution 
During the study period 2005–2008, 572 human C. jejuni isolates and 811 food and 
environmental isolates were collected (and had complete MLST profiles available). The 
estimated number of cases attributable to each source over time (based on the dynamic modified 
Hald model) is shown in Figure 4. These data show that compared with the baseline period 
(2005–2006), the number of cases in the Manawatu region attributed to poultry declined by 74% 
(95% credible interval 49%–94%) in 2008. No evidence was found for a decline in cases 
attributed to nonpoultry sources over the same period (p>0.5) (Figure 4). Similar results were 
obtained for the dynamic version of the Island model (results not shown). 
Summary of Interventions 
Specific food safety and poultry industry interventions were implemented beginning in 
2006, in line with NZFSA’s strategy for reducing the incidence of foodborne campylobacteriosis 
(Table). From April 2007, poultry processors monitored and reported to the NZFSA-
administered National Microbiological Database Campylobacter spp. prevalence in poultry 
flocks by using presence/absence cecal testing and Campylobacter spp. contamination levels in 
poultry carcass rinsates at the end of primary processing (Table). 
In April 2008, mandatory Campylobacter spp. performance targets were introduced based 
on enumerated levels of Campylobacter spp. contamination on poultry carcasses at the end of 
primary processing, with escalating regulatory responses if targets were not met (22). NZFSA 
has subsequently released an updated Campylobacter Risk Management Strategy (23). 
Key informants noted that attention to detail with hygienic practices throughout 
production and primary processing and alterations to the immersion-chiller conditions were key 
areas in which improvements were made. Furthermore, the monitoring of Campylobacter spp. 
contamination levels in poultry carcass rinsates at the end of primary processing and setting 
mandatory Campylobacter spp. performance targets (rather than mandating specific 
interventions) were viewed by both industry and regulator informants as key facilitators of the 
strategy’s success. Page 8 of 18 
Discussion 
New Zealand experienced a marked 50% decline in the rate of campylobacteriosis 
notifications and hospitalizations during 2007 with the 2008 rate >50% lower than the average 
annual incidence for 2002–2006. This decline was sustained in 2009 (Figure 1). This decreased 
incidence implies 70,000 fewer community cases in New Zealand in 2008 compared with the 
peak in 2006, on the basis of the widely used multiplier of 7.6× the number of notified cases 
occurring in the community (24). 
This reduction in incidence corresponds closely in time to the introduction of voluntary 
and regulatory interventions to reduce contamination of poultry with Campylobacter spp. 
Furthermore, patterns of the decline in disease incidence by population subgroup and area, along 
with the lack of plausible alternative explanations, suggest a causal effect from the poultry-
focused interventions. The greater decline in campylobacteriosis in urban populations compared 
to the decline in rural populations (Figure 2) suggests that changes in foodborne transmission 
pathways were a key driver of the decline, compared with exposure pathways more likely to be 
encountered in rural settings (e.g., direct contact with contaminated environments or animals). 
Source attribution modeling also provides supportive evidence that the decline in human 
campylobacteriosis can be largely attributed to a reduction in infection arising from poultry. The 
attribution study suggested a 74% decline in cases originating from poultry sources in 2008 
compared with the baseline for 2005–2006. No statistically significant declines in attribution 
were found for any other sources (Figure 4). 
It is difficult to attribute the decline in poultry-associated human disease to any single 
intervention, because a range of food safety and poultry industry interventions were implemented 
since 2006. Further, the fall in campylobacteriosis rates in New Zealand is unusual in terms of 
the size and speed of the decline, and the regulatory measures that were used. Internationally, a 
small number of countries have reported declines in campylobacteriosis incidence following the 
implementation of control strategies focusing on poultry (25–28). These countries have used 
various interventions, but a commonality has been strengthening on-farm biosecurity and 
monitoring the prevalence of Campylobacter spp.–positive flocks. Page 9 of 18 
Although substantial evidence exists that poultry industry interventions contributed to the 
decline in campylobacteriosis incidence in New Zealand, several alternative explanations should 
be considered. These include the possibility of surveillance artifact, declining poultry 
consumption, declining disease associated with other foods or drinking water, effects of climate, 
and changes in consumer behavior. 
Surveillance artifact is unlikely to have contributed significantly to the decline, however, 
given the magnitude of the reduction, the similarity of temporal trends in hospitalization and 
notification data (Figure 1), the decline occurring across all population subgroups, and the lack 
of similar declines for the comparison group of notifiable enteric diseases (Figure 3). 
Furthermore, the decline in campylobacteriosis in 2007 and 2008 was observed for all 
geographic areas (albeit to varying degrees), which suggests a change in a ubiquitous and 
common exposure. Salmonellosis rates may also have been expected to fall because of the 
potential concomitant effects of the interventions on Salmonella spp. contamination of poultry. 
However, the lack of decline in salmonellosis is not surprising in the New Zealand context 
because Salmonella spp. contamination levels were very low in poultry before the 
implementation of these interventions (29). 
To assess the possible impact of poultry consumption on the decline in 
campylobacteriosis, we examined poultry production data. In New Zealand, poultry production 
approximates poultry consumption because of the closed nature of the production system. Over 
the period of the marked decline in campylobacteriosis incidence (2006–2008), fresh poultry 
production waned by only 5.8% (30). While this fall in production could have affected the 
incidence of poultry-associated foodborne campylobacteriosis, it is unlikely to be sufficient to 
explain the >50% drop in campylobacteriosis notifications occurring over this period. 
Several foodborne pathways of campylobacteriosis (other than poultry) have been 
identified, including red meat and raw milk consumption (8,31). The contribution of these 
pathways to sporadic campylobacteriosis in New Zealand has been estimated to be notably less 
than that of poultry (9,12). The magnitude of the decrease seen in 2008 is such that even if the 
contributions from food sources other than poultry had been eliminated in their entirety, they 
likely could not account for the observed decline in campylobacteriosis. Page 10 of 18 
Contaminated water and other environmental sources have been implicated as a 
transmission pathway of human campylobacteriosis (32,33). Although water is found to be 
contaminated with Campylobacter spp., molecular epidemiologic studies have shown a low 
similarity between these genotypes and those found in human case-patients, suggesting that the 
strains detected in water are relatively apathogenic or that humans have limited exposure to them 
(12,13). Furthermore, a high proportion of New Zealanders receive treated community water 
supplies, with only small gradual increases in the proportion receiving water that meets 
microbiological quality criteria (34). 
Changes in consumer behavior (e.g., hygiene, food preparation, eating out) could have 
plausibly contributed to the decline. However, challenges in altering consumer behavior have 
been acknowledged (35), and, given the rapidity of the decline in incidence, it is unlikely a 
sudden, marked change in consumer behavior could have been a key driver of the decline.  
The effect of climate was considered as a possible driver of the decline. Despite the 
seasonal pattern observed for campylobacteriosis, the main drivers of the association between 
climate and campylobacteriosis remain elusive (36). However, the rapidity of the fall in 
incidence suggests that global climate change factors are unlikely to be key drivers. 
A strength of this study is the multiple data sources that were accessed and analyzed, 
including source attribution techniques and key informant interviews. Nevertheless, a limitation 
of this study in determining the likely cause of the recent decline in campylobacteriosis is the 
descriptive nature of the epidemiologic analysis and the complex epidemiology of 
campylobacteriosis, which means that not all factors that might influence the disease’s incidence 
were examined explicitly. Although validated by studies in 2 other regions, the source attribution 
analyses were from 1 sentinel site only, and this work also has its own limitations (12,13,15). A 
further weakness is that details of specific industry-level interventions to reduce poultry 
contamination are not in the public domain, and therefore cannot be examined in detail. We were 
also unable to examine in detail data on Campylobacter spp. contamination levels of poultry. 
However, summary microbiological data on Campylobacter spp. contamination levels from the 
national database for 2007 and 2008 as published in the updated Campylobacter Risk 
Management Strategy 2010–2013 (23) support a reduction in Campylobacter spp. prevalence 
and counts on poultry over the period of the decline. Page 11 of 18 
Rates of campylobacteriosis have shown marked annual variations in the past, so it will 
be important to assess medium- to long-term trends in disease and its attribution to assess the 
effects of NZFSA’s strategy. Notification and hospitalization data for 2009 indicate that the 
decline in incidence seen in 2008 has been largely sustained (Figure 1). Despite the 2009 rates 
being slightly higher than those of 2008, they still represent a substantial decline compared with 
the average for 2002–2006 (48% for notifications and 50% for hospitalizations). 
Although there are costs associated with implementing industry regulation, these are 
likely to be offset by both the direct and indirect savings from reduced disease effects and lost 
productivity, conservatively estimated to have cost NZ$600 per campylobacteriosis case in 2005 
(37). Given an estimated 70,000 fewer cases of campylobacteriosis in the community in 2008 
than in 2006, this decline represents notable savings to New Zealand society. While progress has 
been made in responding to New Zealand’s campylobacteriosis epidemic, the costs and effects 
are still significant. As such, further research (including evaluating additional interventions) is 
desirable from a public health perspective to enable continued reductions of the still high burden 
posed by campylobacteriosis. 
The findings of this study provide evidence of a successful population-level food safety 
response to a serious public health issue. New Zealand has experienced a prolonged national 
epidemic of campylobacteriosis. Fresh poultry, of which consumption was rising, was implicated 
as the dominant source, and a range of voluntary and regulatory interventions were introduced to 
reduce Campylobacter contamination of poultry. The apparent success of these interventions 
demonstrates approaches other countries could consider for controlling infectious disease 
epidemics linked to specific food sources. This example highlights the importance of integrated 
public health surveillance that includes upstream hazards as well as disease (38). Finally, the 
success of the response shows the value of collaboration between industry, food safety 
regulators, and public health researchers in addressing important food safety issues.  
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Table. Key regulator and industry interventions and activities introduced in 2006–2008 to reduce poultry-associated foodborne 
campylobacteriosis, New Zealand* 
Step  Initiative  Aim  Comments 
Primary 
production 
Development of voluntary Broiler 
Growing Biosecurity Manual by 
industry, building on existing industry 
biosecurity manuals and codes of 
practice 
Identify effective on-farm biosecurity 
procedures in the New Zealand 
context; set industry best practice for 
on-farm biosecurity to help prevent 
Campylobacter spp. infection of flocks 
Implemented in August 2007; 
developed by industry based on 
evaluation of existing on-farm 
biosecurity procedures and review of 
national and international best 
practice† 
  Improvements in procedures for 
catching and transporting birds and for 
cleaning/drying of transport crates 
Reduce possible cross infection 
between infected and non-infected 
birds during transport 
 
  Monitoring and reporting prevalence of 
Campylobacter spp. in cecal samples 
taken from birds from each growing 
shed each time birds are sent for 
processing 
Determine the proportion of infected 
flocks; aid investigation of risk factors 
for flock infection; identify poor-
performing farms 
Implemented April 2007; reported to 
National Microbiological Database, 
administered by NZFSA‡ 
 
Processing  Monitoring and reporting enumerated 
levels of Campylobacter spp. from 
rinsates of bird carcasses exiting the 
immersion-chiller (at the end of 
primary processing) 
Assess the effectiveness of risk 
mitigation strategies implemented on-
farm and during processing in 
reducing Campylobacter levels; inform 
development of national targets for 
Campylobacter spp. contamination at 
the end of primary processing 
Implemented April 2007; reported to 
the National Microbiological Database, 
administered by NZFSA 
  Industry exchange of information and 
implementation of improvements 
during primary processing (particularly 
immersion-chiller conditions) 
Identify cost-effective processing 
interventions that reduce the levels of 
Campylobacter spp. on broilers at 
completion of primary processing; 
inform an updated industry Code of 
Practice for primary poultry processing 
2006–2008 
 
  Implementation of an updated industry 
Code of Practice for primary 
processing of poultry (slaughter and 
dressing) 
Set industry best practice for primary 
processing based on knowledge 
gained from previous processing trials 
Issued August 24, 2007; implemented 
March 2008§ 
  Mandatory targets for Campylobacter 
spp. contamination levels on poultry 
carcasses after primary processing 
Enable regulatory action to occur if 
poultry processors exceed a certain 
level of Campylobacter spp. 
contamination on broiler carcasses at 
the end of primary processing (on 
exiting the immersion-chiller) 
Implemented April 2008; reported to 
the National Microbiological Database 
administered by NZFSA 
 
Retail  Voluntary use of leak-proof packaging  Reduce potential for cross-
contamination from contaminated 
packaging in retail and home settings 
Introduced for whole carcasses by 
most primary processors. Introduced 
for portion packs by some 
supermarkets 
  Intermittent monitoring of 
Campylobacter spp. contamination of 
retail poultry 
Assess Campylobacter spp. levels in 
retail packs purchased by consumers; 
inform interventions and code of 
practice for secondary processing 
Reflects Campylobacter spp. levels at 
primary processing and subsequent 
changes due to secondary processing, 
storage, distribution, and 
processing/handling at the retail outlet 
Consumer  Enhanced consumer education  Increase public awareness of food 
safety risk mitigation behaviors 
Initially instigated in 1998 by NZFSA 




Enhanced human campylobacteriosis 
surveillance and source attribution 
research 
Monitor source attribution of human 
campylobacteriosis to guide future 
interventions 
Source attribution work is ongoing to 
monitor the proportion of human 
campylobacteriosis cases attributable 
to different sources and transmission 
pathways 
*NZFSA, New Zealand Food Safety Authority. 
†www.pianz.org.nz/Documents/Version_1.pdf.  
‡Mandatory cecal testing was discontinued July 2009. 
§www.foodsafety.govt.nz/elibrary/industry/Code_Practice-Zealand_Food.htm. Page 17 of 18 
 
 
Figure 1. Campylobacteriosis notification rates per 100,000 population by year, 1980–2009, and 
hospitalization rates per 100,000 population by year, 1996–2009, New Zealand. Arrows indicate key 
interventions. 
 
Figure 2. Rate ratios of campylobacteriosis notifications in New Zealand by grade of rurality for 2002–
2006 and 2008. Main urban area was used as reference value for rate ratios. Error bars indicate 95% 
confidence intervals. Page 18 of 18 
 
Figure 3. Annual campylobacteriosis notification rates per 100,000 population compared with annual 
notification rates per 100,000 population for salmonellosis, cryptosporidiosis, and yersiniosis, New 
Zealand, 1997–2008. 
 
Figure 4. Number of cases attributed to source by year as determined by the modified Hald model in the 
Manawatu region of New Zealand. Error bars indicate 95% credible intervals. *2005 data are March 
through December only.  